| Serial Number | 90765924 |
| Word Mark | CYCART |
| Filing Date | Thursday, June 10, 2021 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, June 15, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, placental-derived cells, umbilical cord cells, placental-derived T cells, chimeric antigen receptor (CAR) T cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering and burn dressing; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds and burns; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen |
| Goods and Services | Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; placental-derived cells, chimeric antigen receptor (CAR) T cells, and placental-derived T cells with a chimeric antigen receptor (CAR), all for use in scientific, laboratory and medical research |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 30, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | Tuesday, January 7, 2020 |
| First Use In Commerce Date | Wednesday, June 2, 2021 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 30, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, January 7, 2020 |
| First Use In Commerce Date | Wednesday, June 2, 2021 |
| Party Name | Celularity Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Florham, NJ 07932 |
| Event Date | Event Description |
| Friday, August 18, 2023 | EXPARTE APPEAL TERMINATED |
| Friday, August 18, 2023 | EXPARTE APPEAL DISMISSED AS MOOT |
| Thursday, June 15, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, June 15, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Thursday, June 15, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, May 31, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, February 14, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 14, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 14, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, December 16, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, December 16, 2022 | EX PARTE APPEAL-INSTITUTED |
| Friday, December 16, 2022 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Friday, December 16, 2022 | EXPARTE APPEAL RECEIVED AT TTAB |
| Thursday, June 16, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, June 16, 2022 | FINAL REFUSAL E-MAILED |
| Thursday, June 16, 2022 | FINAL REFUSAL WRITTEN |
| Wednesday, April 13, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 12, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 9, 2022 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| Tuesday, March 8, 2022 | USE AMENDMENT ACCEPTED |
| Tuesday, March 8, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 8, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 8, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 1, 2022 | ASSIGNED TO EXAMINER |
| Thursday, September 2, 2021 | AMENDMENT TO USE PROCESSING COMPLETE |
| Thursday, September 2, 2021 | USE AMENDMENT FILED |
| Tuesday, June 15, 2021 | TEAS AMENDMENT OF USE RECEIVED |
| Monday, August 30, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, June 14, 2021 | NEW APPLICATION ENTERED |